R&D Systems™ ProDots Human LIF Recombinant Protein

Catalog No.	Quantity
PRD773450	250 μg
PRD773410	50 μg

Catalog No. PRD773450 Supplier R&D Systems™ Supplier No. PRD773450

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The ProDots Recombinant Human LIF Protein is derived from E. coli. The ProDots Recombinant Human LIF Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P15018
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 3976
• Molecular Weight (g/mol): Observed M.W.: 19 kDa, reducing conditions.; Theoretical M.W.: 19.6 kDa
• Quantity: 250 μg
• Source: E. coli-derived human LIF protein Pro24-Phe202
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt at room temperature as supplied. 12 months from date of receipt at 2-8° C as supplied. 1 month at 2-8° C under sterile conditions after reconstitution. 3 months at -20 to -80° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.01 EU per 1μg of the protein by the LAL method.
• Gene Alias: CDF, D factor, DIA, differentiation inhibitory activity, differentiation stimulating factor, Differentiation-stimulating factor, Emfilermin, HILDA, HILDAcholinergic differentiation factor, leukemia inhibitory factor, leukemia inhibitory factor (cholinergic differentiation factor), Melanoma-derived LPL inhibitor, MLPLI
• Common Name: LIF
• Gene Symbol: LIF
• Biological Activity: Measured in a cell proliferation assay using TF-1 human erythroleukemic cells. Kitamura, T. et al. (1989) J. Cell Physiol. 140:323.
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Reconstitution: For a stock solution, reconstitute at 100 μg/mL in sterile PBS, or simply roll ProDot™ directly into cell culture medium for immediate use.
• Expression System: E. coli-derived Pro24 - Phe202